H2OPTX

Medtech

Automated multiplexed hyperspectral imager-based scanner-analyzer for pharmaceutical powder and tablet characterization

Grants
$65K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
12
5 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Robotic scanner-analyzer for rapid, on-the-fly testing for tablet formulation and quality control in pharmaceutical manufacturing$65,290
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1255SharpEyes, LLC——
1256NANODERM SCIENCES, INC.——
1257Bone Health Technologies, Inc.—$3.7M
1258H2OPTX——
1259Tector, Inc.——
1260BioAmp Diagnostics, Inc.——
1261Innerspec Technologies Inc——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 5 granted of 12

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.